AI assistant
Sending…
CONMED Corp — Director's Dealing 2024
May 2, 2024
31971_dirs_2024-05-02_923b6bd4-1930-4f36-9cfc-9d052b70c589.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-04-30
Reporting Person: Beyer Pat (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-30 | Common Stock | P | 3000 | $68.30 | Acquired | 10807 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from 68.29 to 68.40. Full information regarding the number of shares purchased at each separate price will be provided upon request of the commission staff, CONMED or CONMED security holder
More from CONMED Corp
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18